PEP/NEWS — Peptide intel. Daily.

GLP-1 DRUG MUSCLE LOSS TRACKS WITH WEIGHT LOST — NOT THE DRUG ITSELFFISETIN REDUCES VASCULAR SENESCENCE MARKERS IN DOXORUBICIN-TREATED TISSUECREATINE + POWER TRAINING OUTPERFORMS EITHER ALONE IN ADULTS 65+URINARY NANOPROBE NOW DETECTS SENESCENT CELL BURDEN NON-INVASIVELYGLUTAMINE-DRIVEN LIPID SYNTHESIS DECLINES IN AGED MUSCLE STEM CELLSEPITALON EXISTS IN 3 DISTINCT CHEMICAL FORMS WITH DIFFERENT RESEARCH PROFILESEXERCISE EXOSOMES CARRYING eNAMPT ACTIVATE SIRT1 IN AGING LIVER TISSUEDIETARY CHANGE CAN SHIFT BIOLOGICAL AGE CLOCK BY UP TO SEVERAL YEARS GLP-1 DRUG MUSCLE LOSS TRACKS WITH WEIGHT LOST — NOT THE DRUG ITSELFFISETIN REDUCES VASCULAR SENESCENCE MARKERS IN DOXORUBICIN-TREATED TISSUECREATINE + POWER TRAINING OUTPERFORMS EITHER ALONE IN ADULTS 65+URINARY NANOPROBE NOW DETECTS SENESCENT CELL BURDEN NON-INVASIVELYGLUTAMINE-DRIVEN LIPID SYNTHESIS DECLINES IN AGED MUSCLE STEM CELLSEPITALON EXISTS IN 3 DISTINCT CHEMICAL FORMS WITH DIFFERENT RESEARCH PROFILESEXERCISE EXOSOMES CARRYING eNAMPT ACTIVATE SIRT1 IN AGING LIVER TISSUEDIETARY CHANGE CAN SHIFT BIOLOGICAL AGE CLOCK BY UP TO SEVERAL YEARS

Last updated May 19, 2026 — I read this morning's peptide research and picked the items that mattered. Fresh brief tomorrow.

◤ Top story · Lifespan.io
GLP-1 DRUGS DON'T STEAL MUSCLE — NEW STUDY FINDS WEIGHT LOSS IS THE VARIABLE...

*GLP-1 agonists show no extra muscle loss beyond what ordinary caloric deficit produces.*

Lifespan.io

Featured Briefs

◤ Article

FISETIN CUTS VASCULAR AGING MARKERS IN NEW SENOLYTIC STUDY...

Fisetin — a plant-derived senolytic compound studied for clearing damaged cells — reduced premature vascular aging caused by chemotherapy drug doxorubicin in new research. It cut both cellular senescence and mitochondrial oxidative stress in blood vessel tissue. The finding adds to a growing body of senolytic evidence outside conventional drug pipelines.

Aging Cell
◤ Article · Peptide-anchored

AOD-9604 VS SEMAGLUTIDE: METABOLIC MECHANISMS SIDE BY SIDE...

AOD-9604 (a fragment of human growth hormone studied for fat metabolism) and semaglutide (a GLP-1 agonist) both target fat loss — but through very different pathways. This comparison maps the research literature on both compounds side by side. Useful context for anyone tracking the metabolic peptide space.

Research Vials
▶ Video

THE WORLD HAS A SERIOUS PEPTIDE PROBLEM

Apply here to work 1:1 with me and my team: https://linktw.in/TQNxOy If you want to lose 30+ LBs, optimize your hormones and take your physique to the next level using and “enhanced blueprint, watch this video next: https://youtu.be/PjvW

Biohacking Specialist
▶ Video · Peptide-anchored

HOW OFTEN TO TAKE MOTS-C

Are you taking MOTS-c too often and missing the biological rhythm your mitochondria actually need for better energy, fat metabolism, and performance? In this video, I break down how MOTS-c works through AMPK activation, mitochondrial biogen

Regan Archibald
▶ Video

HOW TO OVERCOME SOCIAL ANXIETY | DR. NICK EPLEY

Dr. Nick Epley, PhD, is a professor of behavioral science at the University of Chicago and a leading expert on the science of social connection. We discuss how seemingly small daily interactions with strangers (as well as with people we kno

Andrew Huberman
▶ Video · Peptide-anchored

WHAT DOES MOTS-C PEPTIDE DO

Are you eating clean, exercising consistently, and still struggling with low energy, stubborn weight gain, brain fog, or blood sugar issues? In this video, I break down what MOTS-c peptide is, how this mitochondrial signaling molecule works

Regan Archibald

More Headlines